ArticleStructural heart : the journal of the Heart Team2026
A Novel Invasive Hemodynamic Parameter (V') to Predict Hemodynamic Response to Mitral Transcatheter Edge-to-Edge Repair.
Article in Structural heart : the journal of the Heart Team, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Left atrial (LA) V-wave amplitude can be higher with elevated left ventricular end-diastolic pressure, mitral regurgitation (MR), or both. This may cause hemodynamic and echocardiographic discordance when assessing MR. Identifying more specific hemodynamic correlates to MR severity helps in the setting of discordance. We examined the amplitude of the V-wave relative to the LA mean pressure following the reduction in MR after mitral transcatheter edge-to-edge repair (M-TEER). Methods: A total of 231 patients who underwent M-TEER between 2019 and 2022 with reliable intraprocedural invasive hemodynamic waveforms were included. LA mean and V-wave pressures were measured pre- and post-M-TEER. V' was calculated as follows: (V' = V-wave - mean pressure). Results: Our cohort (median age 79) included 65% and 35% patients with primary mitral regurgitation (PMR) and secondary mitral regurgitation (SMR), respectively. LA mean, V-wave, and V' pressures decreased significantly after M-TEER in both groups. SMR patients had higher LA pressures after M-TEER. Baseline and post-M-TEER V' did not differ among groups. In the overall cohort, pre- and post-M-TEER V' were significantly higher in patients with >2+ residual MR compared to ≤2+ MR. Patients with post-M-TEER V' >13 mmHg had worse composite outcomes of heart failure hospitalization or all-cause mortality (hazard ratio: 3.01; 95% CI: 1.68-5.4; Conclusion: M-TEER decreased LA mean, V-wave, and V' pressures in PMR and SMR. Postprocedural V' provides a useful measure of residual MR and clinical outcomes and guides the adequacy of M-TEER.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.